DSIP (Delta Sleep-Inducing Peptide): Research, Mechanism, and Evidence for Sleep Modulation

What it is

In 1977, two Swiss researchers, Schoenenberger and Monnier, took blood from the brains of sleeping rabbits, injected it into awake rabbits, and watched the awake ones drop into delta sleep, the deepest stage, the one with the slow brain waves. They isolated the molecule responsible: a nine-amino-acid peptide they named delta sleep-inducing peptide, DSIP.

Your body makes it. It shows up in blood and spinal fluid, and it follows a daily rhythm: higher during the day, lower at night, the mirror image of cortisol, the stress hormone. That pattern is why researchers came to see it as something broader than a sleep switch.

Nearly fifty years later, DSIP is still a puzzle. Nobody has found the receptor it acts on. Its mechanism is only partly mapped. And its name oversells it: DSIP does not knock you out. It seems to reshape sleep, adding more deep sleep, rather than force it (Kovalzon & Strekalova, 2006).

What it is studied for

Deep sleep and insomnia, first. Then the sleep disruption that comes with alcohol and benzodiazepine withdrawal, where it did unusually well. Stress hormones, since it lowers evening cortisol. And pain, where it showed a modest effect in old studies. Almost all of this work is from the 1980s and 1990s.

What the evidence actually shows

In humans

The main study gave DSIP by intravenous drip to people with chronic insomnia, nightly for five nights. They fell asleep faster, spent more of the night asleep, and rated themselves fresher in the morning. Sleep recordings showed more slow-wave sleep, and REM sleep was not reduced, which sets DSIP apart from benzodiazepines and antihistamines, both of which cut REM (Schneider-Helmert & Schoenenberger, 1983).

It did its best work in people whose sleep had been wrecked by alcohol or benzodiazepine withdrawal, where it brought the sleep pattern back toward normal. A small narcolepsy study reported better daytime alertness. In chronic pain patients, it lowered pain scores and improved sleep.

The problems: these studies were small, most came from the group that discovered the peptide, many of the stress and withdrawal reports come from Russian groups with little English-language publication, and nobody has run a modern controlled trial (Graf & Kastin, 1984). See how peptides are studied for why that matters.

In animals

Animal work shows DSIP blunting the physical toll of stress: it normalized stress-driven changes in brain chemistry, protected against stress ulcers, and lowered evening cortisol (Sudakov et al., 1995). It also nudges the body’s own opioid system without producing a high or dependence, which may be where the pain effect comes from. In toxicity testing, researchers could not find a lethal dose.

From user reports

People describe deeper, more continuous sleep after several nights rather than on night one, vivid dreams, and feeling clearer the next day. Those who expected a sleeping pill are usually disappointed. There is no study behind any of these reports.

How it works, as far as anyone knows

DSIP seems to act on several brain chemical systems at once rather than through one receptor, which is part of why the receptor has never been found. It increases slow-wave sleep, shortens the time to fall asleep, and leaves REM alone. It lowers evening cortisol and touches other hormone signals, including luteinizing hormone and ACTH.

One indirect effect gets a lot of attention: the body’s largest growth hormone pulse happens during deep sleep, so more deep sleep may mean more growth hormone. DSIP does not stimulate growth hormone itself. That is what ipamorelin and CJC-1295 do, through entirely different mechanisms.

How it is used in studies

The human studies used about 25 nanomoles per kilogram intravenously, roughly 100 to 200 micrograms for an 80 kg adult, on five to ten consecutive nights. Injecting under the skin, which is what users do, absorbs differently, so the numbers may not carry over.

Users report 100 to 300 micrograms under the skin, 30 to 60 minutes before bed, for 10 to 14 nights and then a break. Some run five nights on, two off. DSIP breaks down faster than most peptides: mix it with bacteriostatic water, refrigerate at once, use it within two to three weeks, and do not refreeze. See the storage and reconstitution guide.

Side effects and unknowns

Reported side effects are mild: occasional headache, rare next-morning grogginess, injection-site soreness, and vivid dreams. In the old studies there was no dependence, no withdrawal, no breathing suppression, and no next-day mental fog.

The unknowns are structural. With no known receptor, nobody can say what else it might be acting on. Drug interactions have not been studied. Long-term use has not been studied. And because the molecule is unstable, the dose that actually reaches the brain from a subcutaneous shot is anyone’s guess. See the peptide safety guide.

How it compares to related compounds

• Melatonin helps you fall asleep and resets the body clock. DSIP is about the depth of sleep once you are under. They work differently and people often combine them.
• Epithalon restores melatonin production in aged animals; DSIP acts on sleep structure directly.
• Selank is studied for anxiety; if worry is what keeps you awake, it addresses a different problem than DSIP does.
• Ipamorelin raises growth hormone directly; some people pair it with DSIP on the theory that deeper sleep amplifies the pulse. No study has tested the combination. See the muscle growth guide.
• Sleeping pills (benzodiazepines, Z-drugs, antihistamines) sedate and usually suppress REM. DSIP does neither.

Legal status

Not FDA approved, sold as a research chemical, not a controlled substance in the United States, and not on the WADA Prohibited List. Not approved for medical use in any country we could find.

Frequently Asked Questions

How is DSIP different from melatonin?

Melatonin is about timing: when you get sleepy. DSIP is about depth: how much slow-wave sleep you get. Different jobs, different mechanisms.

Will it make me groggy the next day?

Reports say no; most people describe feeling sharper, likely because the sleep was deeper. Mild grogginess in the first few nights is occasionally mentioned.

Can I take it every night?

Nobody has studied continuous use. The convention is 10 to 14 nights, then a break.

Does DSIP raise growth hormone?

Only indirectly, by adding deep sleep, which is when the big growth hormone pulse happens. It is not a growth hormone secretagogue.

Why isn’t it a real medication?

It breaks down in blood within minutes, which makes it hard to formulate. Its receptor is unknown, which regulators dislike. The trials are small and old, and no company has paid for new ones. See why most peptide evidence is preclinical.

Is it useful for jet lag or shift work?

Not studied. Melatonin has far better evidence for clock problems; DSIP might help with sleep depth once the clock is fixed.

References

1. Schneider-Helmert D, Schoenenberger GA. (1983). Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep. Neuropsychobiology. PubMed
2. Graf MV, Kastin AJ. (1984). Delta-sleep-inducing peptide (DSIP): a review. Neurosci Biobehav Rev. PubMed
3. Kovalzon VM, Strekalova TV. (2006). Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. PubMed
4. Sudakov KV, et al. (1995). Delta-sleep inducing peptide sequelae in the mechanisms of resistance to emotional stress. Ann N Y Acad Sci. PubMed

See also

• Peptide
  Epithalon (Epitalon): Research, Mechanism, and a Careful Look at the Anti-Aging Evidence

  Epithalon is a four-amino-acid peptide from a Russian lab, studied for switching on telomerase and restoring melatonin. It lengthened telomeres in a dish and extended lifespan in mice, and it has never been tested for aging in people.

• Peptide
  CJC-1295: What the Evidence Says About This GHRH Analog

  CJC-1295 is a longer-lasting version of GHRH, the signal that tells the pituitary to release growth hormone. The DAC form raised GH and IGF-1 for days in one small trial; the no-DAC form (Mod GRF 1-29) has no human trial of its own.

• Peptide
  Ipamorelin: What the Evidence Says About This Selective GH Secretagogue

  Ipamorelin is a five-amino-acid peptide that mimics ghrelin to release a pulse of growth hormone, and unlike its predecessors does it without raising cortisol, prolactin, or hunger. Human data: one dosing study and one abandoned surgery trial.